320 related articles for article (PubMed ID: 24141377)
21. Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma.
Olofsson R; Mattsson J; Lindnér P
Int J Hyperthermia; 2013 Sep; 29(6):551-7. PubMed ID: 23865737
[TBL] [Abstract][Full Text] [Related]
22. Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy.
van Iersel LBJ; Koopman M; van de Velde CJH; Mol L; van Persijn van Meerten EL; Hartgrink HH; Kuppen PJK; Vahrmeijer AL; Nortier JWR; Tollenaar RAEM; Punt C; Gelderblom H
Ann Oncol; 2010 Aug; 21(8):1662-1667. PubMed ID: 20110289
[TBL] [Abstract][Full Text] [Related]
23. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
Olofsson Bagge R; Mattsson J; Hafström L
Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
[TBL] [Abstract][Full Text] [Related]
24. A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.
Zeh HJ; Brown CK; Holtzman MP; Egorin MJ; Holleran JL; Potter DM; Bartlett DL
Ann Surg Oncol; 2009 Feb; 16(2):385-94. PubMed ID: 19034580
[TBL] [Abstract][Full Text] [Related]
25. Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.
van Iersel LB; de Leede EM; Vahrmeijer AL; Tijl FG; den Hartigh J; Kuppen PJ; Hartgrink HH; Gelderblom H; Nortier JW; Tollenaar RA; van de Velde CJ
Eur J Surg Oncol; 2014 Nov; 40(11):1557-63. PubMed ID: 25125340
[TBL] [Abstract][Full Text] [Related]
26. Locoregional management of hepatic metastasis from primary uveal melanoma.
Sato T
Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
[TBL] [Abstract][Full Text] [Related]
27. Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.
de Leede EM; Burgmans MC; Kapiteijn E; Luyten GP; Jager MJ; Tijl FG; Hartgrink HH; Grünhagen DJ; Rothbarth J; van de Velde CJ; Verhoef C; Vahrmeijer AL
Melanoma Res; 2016 Dec; 26(6):588-594. PubMed ID: 27513071
[TBL] [Abstract][Full Text] [Related]
28. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
[TBL] [Abstract][Full Text] [Related]
29. Survival and Quality of Life after Isolated Hepatic Perfusion with Melphalan as a Treatment for Uveal Melanoma Liver Metastases - Final Results from the Phase III Randomized Controlled Trial SCANDIUM.
Olofsson Bagge R; Nelson A; Shafazand A; All-Eriksson C; Cahlin C; Elander N; Gustavsson A; Helgadottir H; Kiilgaard JF; Kinhult S; Ljuslinder I; Mattsson J; Rizell M; Sternby Eilard M; Ullenhag GJ; Nilsson JA; Ny L; Lindnér P
Ann Surg; 2024 Feb; ():. PubMed ID: 38420778
[TBL] [Abstract][Full Text] [Related]
30. Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
Meijer TS; Burgmans MC; Fiocco M; de Geus-Oei LF; Kapiteijn E; de Leede EM; Martini CH; van der Meer RW; Tijl FGJ; Vahrmeijer AL
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):841-852. PubMed ID: 30767147
[TBL] [Abstract][Full Text] [Related]
31. [Isolated liver perfusion with melphalan followed by pembrolizumab therapy for unresectable metastases of uveal melanoma to the liver].
Kaprin AD; Ivanov SA; Unguryan VM; Kazantsev AN; Belov YV
Khirurgiia (Mosk); 2023; (7):94-99. PubMed ID: 37379411
[TBL] [Abstract][Full Text] [Related]
32. Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.
Hughes MS; Zager J; Faries M; Alexander HR; Royal RE; Wood B; Choi J; McCluskey K; Whitman E; Agarwala S; Siskin G; Nutting C; Toomey MA; Webb C; Beresnev T; Pingpank JF
Ann Surg Oncol; 2016 Apr; 23(4):1309-19. PubMed ID: 26597368
[TBL] [Abstract][Full Text] [Related]
33. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
Artzner C; Mossakowski O; Hefferman G; Grosse U; Hoffmann R; Forschner A; Eigentler T; Syha R; Grözinger G
Cancer Imaging; 2019 May; 19(1):31. PubMed ID: 31146793
[TBL] [Abstract][Full Text] [Related]
34. Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment.
Heusner TA; Antoch G; Wittkowski-Sterczewski A; Ladd SC; Forsting M; Verhagen R; Scheulen M
Rofo; 2011 Dec; 183(12):1151-60. PubMed ID: 22033849
[TBL] [Abstract][Full Text] [Related]
35. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.
Ben-Shabat I; Hansson C; Sternby Eilard M; Cahlin C; Rizell M; Lindnér P; Mattsson J; Olofsson Bagge R
J Vis Exp; 2015 Jan; (95):52490. PubMed ID: 25650893
[TBL] [Abstract][Full Text] [Related]
36. Regional treatment options for patients with ocular melanoma metastatic to the liver.
Feldman ED; Pingpank JF; Alexander HR
Ann Surg Oncol; 2004 Mar; 11(3):290-7. PubMed ID: 14993024
[TBL] [Abstract][Full Text] [Related]
37. Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases.
van Iersel LB; Hoekman EJ; Gelderblom H; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Hartgrink HH; Kuppen PJ; Nortier JW; Tollenaar RA; van de Velde CJ
Ann Surg Oncol; 2008 Jul; 15(7):1891-8. PubMed ID: 18470571
[TBL] [Abstract][Full Text] [Related]
38. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
[TBL] [Abstract][Full Text] [Related]
39. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
40. Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.
Agarwala SS; Eggermont AM; O'Day S; Zager JS
Cancer; 2014 Mar; 120(6):781-9. PubMed ID: 24301420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
